![Maggie Flanagan LeFlore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Maggie Flanagan LeFlore worked as a Managing Director at MedImmune Ventures, Inc. from 2007 to 2010.
She also worked as a Director at Astria Therapeutics, Inc. and NKT Therapeutics, Inc. In terms of education, she earned a doctorate degree from Indiana University and an undergraduate degree from the University of Kansas.
Former positions of Maggie Flanagan LeFlore
Companies | Position | End |
---|---|---|
MedImmune Ventures, Inc.
![]() MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Private Equity Investor | 2010-03-29 |
ASTRIA THERAPEUTICS, INC. | Director/Board Member | - |
NKT Therapeutics, Inc.
![]() NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Director/Board Member | - |
Training of Maggie Flanagan LeFlore
University of Kansas | Undergraduate Degree |
Indiana University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ASTRIA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
MedImmune Ventures, Inc.
![]() MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
NKT Therapeutics, Inc.
![]() NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Maggie Flanagan LeFlore